174 related articles for article (PubMed ID: 31488436)
1. Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.
Barth BM; Wang W; Toran PT; Fox TE; Annageldiyev C; Ondrasik RM; Keasey NR; Brown TJ; Devine VG; Sullivan EC; Cote AL; Papakotsi V; Tan SF; Shanmugavelandy SS; Deering TG; Needle DB; Stern ST; Zhu J; Liao J; Viny AD; Feith DJ; Levine RL; Wang HG; Loughran TP; Sharma A; Kester M; Claxton DF
Blood Adv; 2019 Sep; 3(17):2598-2603. PubMed ID: 31488436
[TBL] [Abstract][Full Text] [Related]
2. The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.
Cakir Z; Saydam G; Sahin F; Baran Y
J Cancer Res Clin Oncol; 2011 Feb; 137(2):279-86. PubMed ID: 20401667
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.
Ung J; Tan SF; Fox TE; Shaw JJP; Vass LR; Costa-Pinheiro P; Garrett-Bakelman FE; Keng MK; Sharma A; Claxton DF; Levine RL; Tallman MS; Cabot MC; Kester M; Feith DJ; Loughran TP
Blood Rev; 2022 Sep; 55():100950. PubMed ID: 35487785
[TBL] [Abstract][Full Text] [Related]
4. Liposomal codelivery of a synergistic combination of bioactive lipids in the treatment of acute myeloid leukemia.
Tan KB; Ling LU; Bunte RM; Chng WJ; Chiu GN
Nanomedicine (Lond); 2014 Aug; 9(11):1665-79. PubMed ID: 24294981
[TBL] [Abstract][Full Text] [Related]
5. The unfolding role of ceramide in coordinating retinoid-based cancer therapy.
Ghandour B; Dbaibo G; Darwiche N
Biochem J; 2021 Oct; 478(19):3621-3642. PubMed ID: 34648006
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic.
Kester M; Bassler J; Fox TE; Carter CJ; Davidson JA; Parette MR
Biol Chem; 2015 Jun; 396(6-7):737-47. PubMed ID: 25838296
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-tamoxifen regimen targets bioenergetic elements in acute myelogenous leukemia.
Morad SA; Ryan TE; Neufer PD; Zeczycki TN; Davis TS; MacDougall MR; Fox TE; Tan SF; Feith DJ; Loughran TP; Kester M; Claxton DF; Barth BM; Deering TG; Cabot MC
J Lipid Res; 2016 Jul; 57(7):1231-42. PubMed ID: 27140664
[TBL] [Abstract][Full Text] [Related]
8. Ceramide as a Target of Marine Triterpene Glycosides for Treatment of Human Myeloid Leukemia.
Yun SH; Shin SW; Stonik VA; Park JI
Mar Drugs; 2016 Nov; 14(11):. PubMed ID: 27827870
[TBL] [Abstract][Full Text] [Related]
9. Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.
Morad SAF; MacDougall MR; Abdelmageed N; Kao LP; Feith DJ; Tan SF; Kester M; Loughran TP; Wang HG; Cabot MC
Exp Cell Res; 2019 Aug; 381(2):256-264. PubMed ID: 31112736
[TBL] [Abstract][Full Text] [Related]
10. The clinical potential of sphingolipid-based therapeutics.
Fox TE; Finnegan CM; Blumenthal R; Kester M
Cell Mol Life Sci; 2006 May; 63(9):1017-23. PubMed ID: 16568241
[TBL] [Abstract][Full Text] [Related]
11. Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells.
Amiri B; Ahmadvand H; Farhadi A; Najmafshar A; Chiani M; Norouzian D
Drug Dev Ind Pharm; 2018 Aug; 44(8):1371-1376. PubMed ID: 29532687
[TBL] [Abstract][Full Text] [Related]
12. Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics.
Morad SA; Tan SF; Feith DJ; Kester M; Claxton DF; Loughran TP; Barth BM; Fox TE; Cabot MC
Biochim Biophys Acta; 2015 Jul; 1851(7):919-28. PubMed ID: 25769964
[TBL] [Abstract][Full Text] [Related]
13. Ceramide-based therapeutics for the treatment of cancer.
Barth BM; Cabot MC; Kester M
Anticancer Agents Med Chem; 2011 Nov; 11(9):911-9. PubMed ID: 21707481
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
15. Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate.
Zhang H; Wang ZY; Gong W; Li ZP; Mei XG; Lv WL
Int J Pharm; 2011 Jul; 414(1-2):56-62. PubMed ID: 21596128
[TBL] [Abstract][Full Text] [Related]
16. Potential new antimalarial chemotherapeutics based on sphingolipid metabolism.
Pankova-Kholmyansky I; Flescher E
Chemotherapy; 2006; 52(4):205-9. PubMed ID: 16675903
[TBL] [Abstract][Full Text] [Related]
17. Click reactions with functional sphingolipids.
Fink J; Seibel J
Biol Chem; 2018 Sep; 399(10):1157-1168. PubMed ID: 29908120
[TBL] [Abstract][Full Text] [Related]
18. Encapsulation of vinblastine into new liposome formulations prepared from triticum (wheat germ) lipids and its activity against human leukemic cell lines.
Maswadeh H; Hatziantoniou S; Demetzos C; Dimas K; Georgopoulos A; Rallis M
Anticancer Res; 2000; 20(6B):4385-90. PubMed ID: 11205276
[TBL] [Abstract][Full Text] [Related]
19. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development.
Tran MA; Smith CD; Kester M; Robertson GP
Clin Cancer Res; 2008 Jun; 14(11):3571-81. PubMed ID: 18519791
[TBL] [Abstract][Full Text] [Related]
20. Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia.
Melland-Smith M; Ermini L; Chauvin S; Craig-Barnes H; Tagliaferro A; Todros T; Post M; Caniggia I
Autophagy; 2015 Apr; 11(4):653-69. PubMed ID: 25853898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
